RT Puhua Genomics

Venture Capital

Portfolio

companies

Oxford Nanopore Technologies

Oxford Nanopore Technologies develops DNA and RNA sequencing systems for scientific research and public health.

Series D+13 October 2020

£84.4M

Oxford Nanopore secures £84.4m in Series H+ funding to accelerate manufacturing operations

The financing round draws participation from International Holdings Company, RPMI Railpen and RT Puhua Genomics.

"We are delighted to welcome our new shareholders,"

— Gordon Sanghera, CEO